Co-Authors
This is a "connection" page, showing publications co-authored by Alfred Kim and Maximilian Konig.
Connection Strength
1.016
-
Inflammatory arthritis in patients with COVID-19. Transl Res. 2021 06; 232:49-59.
Score: 0.233
-
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation. Expert Rev Clin Immunol. 2020 12; 16(12):1185-1204.
Score: 0.229
-
A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic. ACR Open Rheumatol. 2020 Aug; 2(8):491-495.
Score: 0.224
-
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis. 2020 10; 79(10):1386-1388.
Score: 0.220
-
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666.
Score: 0.056
-
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736.
Score: 0.055